FDA Panel Conflict Of Interest Restrictions Too Stringent Say Senators
New measures introduced in 2007 to restrict medical devices experts with potential conflicts of interest from advising the US Food and Drug Administration are too stringent, say Senators who are proposing new legislation to relax regulations that they say are getting in the way of bringing innovative products to market...

Senators propose relaxing FDA conflict rules
WASHINGTON (Reuters) - A bill that would loosen conflict of interest rules for advisers to the Food and Drug Administration has been proposed by three U.S. senators seeking to speed up review times for medical devices.